Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Porcine reproductive and respiratory syndrome inactivated vaccine (CH-1a strain)
- Development stage
- Unknown
- Lead developer
- Sinder
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
This is an inactivated veterinary vaccine developed by Youbang Pharmaceutical for the prevention of Porcine Reproductive and Respiratory Syndrome (PRRS). The vaccine is formulated using the CH-1a strain, which is a classical North American-type Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) belonging to lineage 8. As an inactivated vaccine, it contains killed viral particles that elicit a protective immune response, including the production of neutralizing antibodies, without the risk of viral replication or reversion to virulence. It is indicated for the immunization of pigs to reduce reproductive failure in sows and respiratory symptoms in piglets and growing pigs caused by PRRSV infection. The CH-1a strain is a well-established vaccine strain in the Chinese veterinary market.
- Other names
- 猪繁殖与呼吸综合征灭活疫苗(CH-1a株)PRRSV inactivated vaccine (CH-1a strain)Porcine reproductive and respiratory syndrome virus (PRRSV) inactivated vaccine
Beyond the preview
Go deeper on Porcine reproductive and respiratory syndrome inactivated vaccine (CH-1a strain).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Porcine reproductive and respiratory syndrome inactivated vaccine (CH-1a strain).